Friday, March 27, 2020 CCTG and its scope of research has been deemed an essential service by Queen’s University and we continue to be operational for our sites and trial patients. Given the critical nature of our research, we continue to monitor our activities and how trial adjustments can be made to ensure that patients can be managed on protocols. The CCTG Operations and Statistics Centre has successfully completed the transition to a remote work environment with a small number of support staff in the offices. In the coming weeks, as we all adapt to the “new normal”, our teams will be focusing on improving our capabilities and approaches to remote work to ensure ongoing trial activities continue. The Group's leadership is also looking at options for remote spring meetings for our committees and developing new trial proposals. Please visit the CCTG COVID-19 page for the most up to date information and trial management guidance over the coming weeks. New Resources Government of Canada: Management of clinical trials during the COVID-19 pandemic FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic NIH Memo Additional Guidance Regarding Alternative Procedures for Clinical Trials Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic
